Kenneth Edward Randall

Insider Reports History

Location
London, United Kingdom
Signature
/s/ Thomas Nicholls
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kenneth Edward Randall:

Company Role Class Num Shares Value Price $ Report Date Ownership
TC BioPharm (Holdings) plc 10%+ Owner Ordinary Shares [ADS] 136,834 $157,359 $1.15 30 Nov 2022 By Renaissance Capital Partners Ltd
TC BioPharm (Holdings) plc 10%+ Owner Ordinary Shares [ADS] 2,008 $2,309 $1.15 30 Nov 2022 Direct
TC BioPharm (Holdings) plc 10%+ Owner Warrants 106,129 30 Nov 2022 By Renaissance Capital Partners Ltd
TC BioPharm (Holdings) plc 10%+ Owner Series A Warrants 70,000 30 Nov 2022 By Renaissance Capital Partners Ltd
TC BioPharm (Holdings) plc 10%+ Owner Series B Warrants 70,000 30 Nov 2022 By Renaissance Capital Partners Ltd

Insider Reports Filed by Kenneth Edward Randall

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TCBPY TC BioPharm (Holdings) plc 30 Nov 2022 3 +$350,000 4/A 10%+ Owner 11 Jan 2023, 14:59
TCBPY TC BioPharm (Holdings) plc 24 May 2022 1 +$23,923 4 10%+ Owner 14 Jul 2022, 21:56
TCBPY TC BioPharm (Holdings) plc 10 Feb 2022 0 $0 3 10%+ Owner 20 May 2022, 10:39